These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 878467)

  • 1. The treatment of the nephritis of lupus erythematosus.
    West J Med; 1977 Jun; 126(6):479-84. PubMed ID: 878467
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of patients with systemic lupus erythematosus, including nephritis, using chlorambucil.
    Snaith ML; Holt JM; Oliver DO; Stephenson A
    Ann Rheum Dis; 1973 May; 32(3):279-80. PubMed ID: 4715550
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controlled trial of cyclophosphamide, azathioprine and chlorambucil in lupus nephritis (the double-blind method)].
    Ivanova MM; Nasonova VA; Solov'ev SK; Akhnazarova VD; Speranskiĭ AI
    Vopr Revm; 1981; (2):11-8. PubMed ID: 7034366
    [No Abstract]   [Full Text] [Related]  

  • 4. The course of lupus nephritis: a clinical-pathological correlation of fifty patients.
    Striker GE; Kelly MR; Quadracci LJ; Scribner BH
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1141-66. PubMed ID: 4803308
    [No Abstract]   [Full Text] [Related]  

  • 5. Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis.
    Jedlickova H; Bohmová J; Sirotkova A
    Int J Dermatol; 2008 Dec; 47(12):1315-6. PubMed ID: 19126028
    [No Abstract]   [Full Text] [Related]  

  • 6. Lupus nephritis treated with a cytostatic agent. A case of systemic lupus erythematosus with lupus nephritis treated with 6-mercaptopurine.
    Lorenzen I; Brun C; Videbaek AA
    Dan Med Bull; 1966 Oct; 13(6):151-4. PubMed ID: 5927699
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of lupus nephritis with azathioprine.
    Maher JF; Schreiner GE
    Arch Intern Med; 1970 Feb; 125(2):293-8. PubMed ID: 5412919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of cytotoxic immunosuppressive agents on the level of urinary seromucoids and cathepsins in lupus nephritis].
    Stepanova NS; Solov'ev SK; Kaĭnova AS; Ivanova MM
    Ter Arkh; 1980; 52(6):116-9. PubMed ID: 7404377
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenocorticosteroids in lupus nephritis.
    Ginzler EM; Kaplan D
    Transplant Proc; 1975 Mar; 7(1):109-12. PubMed ID: 1091044
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil.
    Snaith ML; Holt JM; Oliver DO; Dunnill MS; Halley W; Stephenson AC
    Br Med J; 1973 Apr; 2(5860):197-201. PubMed ID: 4700007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous administration of high doses (pulse therapy) of methylprednisolone in lupus nephritis].
    Ivanova MM; Solov'ev SK; Speranskiĭ AI; Nasonov EL
    Ter Arkh; 1983; 55(7):114-9. PubMed ID: 6623376
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of lupus nephropathy].
    Conde Olasagasti J; Ortuño Mirete J; Botella Garciá J
    Rev Clin Esp; 1973 Jan; 128(1):63-70. PubMed ID: 4687295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ultra-high (shock) doses of methylprednisolone in lupus nephritis].
    Solov'ev SK; Ivanova MM
    Ter Arkh; 1980; 52(4):121-3. PubMed ID: 7404327
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dynamic studies of skin microcirculation during treatment of lupus nephritis with cytostatic immunosuppressants].
    Mach ES; Solov'ev SK; Ivanova MM
    Ter Arkh; 1980; 52(6):113-6. PubMed ID: 7404376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of systemic lupus erythematosus with immunosupressive agents. Results of our experience and review of the literature].
    Kahn MF; Rambouts C; de Sèze S
    Sem Hop; 1971 Feb; 47(7):435-45. PubMed ID: 4323077
    [No Abstract]   [Full Text] [Related]  

  • 17. [Undesirable side effect of glucocorticoids in the treatment of systemic lupus erythematosus].
    Prikryl P; Kunovská VL
    Vnitr Lek; 1977 Mar; 23(3):260-4. PubMed ID: 855220
    [No Abstract]   [Full Text] [Related]  

  • 18. Sweet's syndrome and systemic lupus erythematosus.
    Gollol-Raju N; Bravin M; Crittenden D
    Lupus; 2009 Apr; 18(4):377-8. PubMed ID: 19276309
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic lupus erythematosus--immunoregulatory therapies.
    Miller ML; Steinberg AD
    Clin Rheum Dis; 1983 Dec; 9(3):617-28. PubMed ID: 6360516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk factors in the development of steroid-induced hypertension in patients with nephritis].
    Kutyrina IM; Klepikov PV; Tareeva IE
    Klin Med (Mosk); 1985 Jun; 63(6):44-8. PubMed ID: 4033027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.